HNGE

Hinge Health

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 63.6%
Negative

Neutral
Business Wire
yesterday
Hinge Health's 2026 State of Musculoskeletal Care Report reveals stark gaps in traditional care
SAN FRANCISCO--(BUSINESS WIRE)--Today, Hinge Health (NYSE: HNGE) released its sixth annual State of Musculoskeletal (MSK) Care Report, revealing how today's fragmented healthcare system leaves many people unsure how to pursue treatment for MSK pain. Hinge Health surveyed 1,000 people living with MSK pain alongside 295 healthcare providers to understand the systemic challenges and opportunities for industry-wide improvements. The dual-perspective survey – along with real patient and provider sto.
Hinge Health's 2026 State of Musculoskeletal Care Report reveals stark gaps in traditional care
Positive
Zacks Investment Research
2 days ago
Will Hinge Health Inc. (HNGE) Beat Estimates Again in Its Next Earnings Report?
Hinge Health Inc. (HNGE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Hinge Health Inc. (HNGE) Beat Estimates Again in Its Next Earnings Report?
Neutral
Business Wire
2 days ago
Hinge Health to announce fourth quarter and full year 2025 financial results on February 10, 2026
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health Q4 2025 earnings date press release.
Hinge Health to announce fourth quarter and full year 2025 financial results on February 10, 2026
Positive
The Motley Fool
1 month ago
Up 44% Since IPO: Why a Major Fund Just Made a $45 Million Bet on This Digital Health Stock
Connecticut-based fund Braidwell initiated a position in HNGE last quarter, adding 910,476 shares worth an estimated $44.7 million. The transaction represents 1.81% of Braidwell's reportable AUM.
Up 44% Since IPO: Why a Major Fund Just Made a $45 Million Bet on This Digital Health Stock
Positive
Zacks Investment Research
1 month ago
Can Hinge Health Inc. (HNGE) Climb 29.59% to Reach the Level Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 29.6% in Hinge Health Inc. (HNGE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Can Hinge Health Inc. (HNGE) Climb 29.59% to Reach the Level Wall Street Analysts Expect?
Neutral
Business Wire
1 month ago
Hinge Health Reduces MRIs and X-Rays for Back Pain by 60%
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced a new study showing that participants in its chronic back pain program had substantially fewer imaging visits, such as X-rays and MRIs, compared to a similar group of individuals who sought traditional PT care. The peer-reviewed study, published in The Journal of Health Economics and Outcomes Research found that of the 4,330 participants, those who used Hinge Health had 60% fewer imaging visits for low back pain at.
Hinge Health Reduces MRIs and X-Rays for Back Pain by 60%
Neutral
Business Wire
2 months ago
Hinge Health announces $250 million share repurchase program
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced that its board of directors has authorized a $250 million share repurchase program. “During the first three quarters of 2025, we generated $108 million in cash from operations and $118 million in free cash flow1, reflecting the strength and scalability of our business model,” said James Budge, CFO, Hinge Health. “We maintain a robust balance sheet, with nearly $500 million in cash and investments as of the end of Q3.
Hinge Health announces $250 million share repurchase program
Neutral
Seeking Alpha
2 months ago
Hinge Health, Inc. (HNGE) Q3 2025 Earnings Call Transcript
Hinge Health, Inc. ( HNGE ) Q3 2025 Earnings Call November 4, 2025 4:30 PM EST Company Participants Bianca Buck Daniel Perez - Co-Founder, CEO & Director James Pursley - President James Budge - Chief Financial Officer Conference Call Participants Rishi Jaluria - RBC Capital Markets, Research Division Jessica Tassan - Piper Sandler & Co., Research Division Saket Kalia - Barclays Bank PLC, Research Division Jailendra Singh - Truist Securities, Inc., Research Division Scott Schoenhaus - KeyBanc Capital Markets Inc., Research Division David Grossman - Stifel, Nicolaus & Company, Incorporated, Research Division Bradley Sills - BofA Securities, Research Division Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Craig Hettenbach - Morgan Stanley, Research Division Brian Peterson - Raymond James & Associates, Inc., Research Division Richard Close - Canaccord Genuity Corp., Research Division Scott Berg - Needham & Company, LLC, Research Division Presentation Operator Ladies and gentlemen, thank you for joining us, and welcome to the Hinge Health Third Quarter 2025 Earnings Call. [Operator Instructions] I will now hand the conference over to Bianca Buck, Head of Investor Relations.
Hinge Health, Inc. (HNGE) Q3 2025 Earnings Call Transcript
Negative
CNBC Television
2 months ago
Hinge Health CEO Daniel Perez talks quarterly results as stock sinks 5%
Hinge Health CEO Daniel Perez talks quarterly results as stock sinks 5%.
Hinge Health CEO Daniel Perez talks quarterly results as stock sinks 5%
Neutral
Business Wire
2 months ago
Hinge Health reports third quarter 2025 financial results
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2025. “With healthcare costs rising dramatically, our mission to automate care delivery has never been more urgent,” said Daniel Perez, Co-Founder and CEO, Hinge Health. “This quarter we surpassed 1.5 million lifetime members, delivered year-over-year revenue growth of 53%, and generated record free cash flow. Our AI-powered platform is transforming care at.
Hinge Health reports third quarter 2025 financial results